rs199659429

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_024306.5(FA2H):ā€‹c.401T>Gā€‹(p.Val134Gly) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000013 ( 0 hom., cov: 33)
Exomes š‘“: 0.00056 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

FA2H
NM_024306.5 missense

Scores

7
4
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.05
Variant links:
Genes affected
FA2H (HGNC:21197): (fatty acid 2-hydroxylase) This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012597203).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FA2HNM_024306.5 linkuse as main transcriptc.401T>G p.Val134Gly missense_variant 3/7 ENST00000219368.8 NP_077282.3
FA2HXM_011523317.4 linkuse as main transcriptc.401T>G p.Val134Gly missense_variant 3/6 XP_011521619.1
FA2HXM_011523319.3 linkuse as main transcriptc.161T>G p.Val54Gly missense_variant 3/7 XP_011521621.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FA2HENST00000219368.8 linkuse as main transcriptc.401T>G p.Val134Gly missense_variant 3/71 NM_024306.5 ENSP00000219368 P1Q7L5A8-1
FA2HENST00000569949.1 linkuse as main transcriptc.203T>G p.Val68Gly missense_variant 3/54 ENSP00000464576
FA2HENST00000567683.5 linkuse as main transcriptc.364-8189T>G intron_variant, NMD_transcript_variant 2 ENSP00000455126

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
1
AN:
152156
Hom.:
0
Cov.:
33
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000562
AC:
820
AN:
1459712
Hom.:
0
Cov.:
32
AF XY:
0.000562
AC XY:
408
AN XY:
726136
show subpopulations
Gnomad4 AFR exome
AF:
0.0000897
Gnomad4 AMR exome
AF:
0.000359
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00162
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.0110
Gnomad4 NFE exome
AF:
0.0000927
Gnomad4 OTH exome
AF:
0.000863
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000131
AC:
2
AN:
152272
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00000666
Hom.:
0
ExAC
AF:
0.00771
AC:
935

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMar 12, 2016This sequence change replaces valine with glycine at codon 134 of the FA2H protein (p.Val134Gly). The valine residue is highly conserved and there is a moderate physicochemical difference between valine and glycine. While this variant is present in population databases (rs199659429), the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in an individual with a FA2H-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C35"). In summary, this variant is a rare missense change with uncertain impact on protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.19
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.65
D;T
Eigen
Benign
0.12
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.80
T;T
MetaRNN
Benign
0.013
T;T
MetaSVM
Uncertain
0.30
D
MutationAssessor
Pathogenic
3.6
H;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.30
T
PROVEAN
Pathogenic
-6.5
D;.
REVEL
Pathogenic
0.73
Sift
Benign
0.035
D;.
Sift4G
Pathogenic
0.0
D;.
Polyphen
0.15
B;.
Vest4
0.67
MPC
0.45
ClinPred
0.10
T
GERP RS
4.5
Varity_R
0.62
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199659429; hg19: chr16-74761247; API